Sodium Hydroxide → alpha-{6(R)-[1(S)-Carboxy-3-phenylpropylamino]-3(R)-isopropyl-5-oxoperhydro-1,4-thiazepin-4-yl}acetic acid
Reaction equation
C([O:3][C:4]([C@@H:6]([NH:15][C@H:16]1[CH2:22][S:21][CH2:20][C@@H:19]([CH:23]([CH3:25])[CH3:24])[N:18]([CH2:26][C:27]([OH:29])=[O:28])[C:17]1=[O:30])[CH2:7][CH2:8][C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1)=[O:5])C.[OH-].[Na+]>>[C:4]([C@@H:6]([NH:15][C@H:16]1[CH2:22][S:21][CH2:20][C@@H:19]([CH:23]([CH3:25])[CH3:24])[N:18]([CH2:26][C:27]([OH:29])=[O:28])[C:17]1=[O:30])[CH2:7][CH2:8][C:9]1[CH:10]=[CH:11][CH:12]=[CH:13][CH:14]=1)([OH:5])=[O:3]Participants
3
Reactant 2
Product 1
Procedure
160 mg of α-{6(R)-[1(S)-ethoxycarbonyl-3-phenylpropylamino]-3(R)-isopropyl-5-oxoperhydro-1,4-thiazepin-4-yl}acetic acid (prepared as described in Example 28 above) were hydrolyzed with aqueous sodium hydroxide in the same manner as described in Example 5, giving 113 mg of the title compound as a powder.
Sources & evidence
- ORD record
- ord-86b4ad5d463543afa68e3403c95c5172
- Source dataset
- uspto-grants-1987_10
- Patent number
- US04699905
Reaction notes
Loading…